Facet Biotech Corporation (NASDAQ: FACT) today announced that its board of directors has reviewed Biogen Idec Inc.'s (Nasdaq: BIIB) unsolicited ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE